Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV001179568 | SCV001344260 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-11-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002067901 | SCV002493459 | likely benign | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2023-11-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001179568 | SCV002649012 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2022-10-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV004006576 | SCV004814629 | likely benign | Marfan syndrome | 2023-03-04 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004538409 | SCV004712606 | likely benign | FBN1-related disorder | 2023-07-19 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |